Promising lyme vaccine moves to final testing phase
NCT ID NCT07226882
First seen Nov 12, 2025 · Last updated Jun 13, 2026 · Updated 31 times
Summary
This study tests a new Lyme disease vaccine (VLA15) in about 200 healthy adults aged 18 to 44. Participants receive five shots over two years—four of the vaccine and one of salt water—to see if different timing schedules are safe and produce a strong immune response. The goal is to find the best way to protect people from Lyme disease.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for LYME DISEASE are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
IMA Clinical Research Warren
Warren Township, New Jersey, 07059, United States
-
Northeast Clinical Trials Group
Scranton, Pennsylvania, 18510, United States
-
Preferred Primary Care Physicians
Uniontown, Pennsylvania, 15401, United States
-
Preferred Primary Care Physicians, Preferred Clinical Research (Ofc 18)
Pittsburgh, Pennsylvania, 15236, United States
-
Smith Allergy & Asthma Specialists
Horseheads, New York, 14845, United States
-
Smith Allergy and Asthma Specialists
Cortland, New York, 13045, United States
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.